Menu

Head of Global Health Security Ousted from White House

The position was eliminated the same week a new Ebola outbreak was declared in the Democratic Republic of the Congo.

May 10, 2018
Shawna Williams

Tim ZiemerWIKIMEDIA, CDC GLOBALTim Ziemer, a member of the White House’s National Security Council (NSC) who was in charge of global health security, abruptly left his post on Tuesday (May 8), the Huffington Post reports. An NSC spokesperson tells the publication that the change reflected a reorganization, and that Ziemer departed “on the warmest of terms.”

“It is unclear in his absence who at the White House would be in charge of a pandemic,” Beth Cameron of the Nuclear Threat Initiative tells the Huffington Post, calling it “a situation that should be immediately rectified.” Cameron was a senior director for global health security and biodefense on the previous administration’s NSC staff.

See “CDC to Drastically Cut Efforts to Prevent Global Disease Outbreaks

The departure occured the same day that the World Health Organization announced a new outbreak of Ebola in the Democratic Republic of the Congo. During a 2014–2015 outbreak of the virus that killed more than 11,000 people in West Africa, the US Congress had set aside funds to combat the epidemic; in another announcement made Tuesday, the White House proposed that Congress take back $252 million of that allocation.

Ron Klain, the former “Ebola czar” who coordinated the response of President Barack Obama’s administration to the earlier outbreak, tells The Atlantic that “having some money left over was intentional,” as it allows the United States Agency for International Development (USAID) to move quickly to try to contain future disease events. He adds that “if Congress accepts Trump’s proposal, USAID will have no funding for a response when the next crisis comes, and it will have to wait until Congress passes new funding, or diverts funds from some other, then-existing disaster response. . . . It is crazily short-sighted to do this.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!